March is National Kidney Month – a time to raise awareness and learn more about kidney health and kidney disease. Earlier in ...

Ozempic may worsen your condition. Additionally, there have been reports of acute (sudden) kidney injury and worsening of chronic kidney disease with Ozempic since the drug was made available on ...

Novo Nordisk already has broad FDA approvals in hand for its injected semaglutide products Ozempic and Wegovy to reduce the ...

Treatment with semaglutide improved maximum walking distance in patients with type 2 diabetes (T2D) and symptomatic peripheral artery disease (PAD), according to results from the STRIDE trial ...

Novo Nordisk's Ozempic has been shown to improve waking distance and quality of life in people with type 2 diabetes (T2D) and ...

In brief ... 💊 A new international clinical trial found that oral semaglutide reduces the risk of major cardiovascular ...

Novo Nordisk has submitted a supplemental application to the FDA for Rybelsus 14 mg to lower cardiovascular risk in adults ...

Too often, patients with chronic kidney disease get diagnosed too late – if at all. Addressing risk factors early can stave ...

Novo Nordisk's Phase 3b STRIDE trial shows Ozempic improves walking distance in peripheral artery disease, while the SOUL ...

Results from the SUMMIT trial suggest that tirzepatide is as effective in preventing heart failure events in those with ...

The overall rate of cardiovascular death or worsening heart failure, the trial's primary endpoint, was higher in the 60% of study participants who also had chronic kidney disease. However ...